Company Overview and News

 
A2 Milk drops 3 per cent as sharemarket edges lower

2018-05-22 nzherald.co.nz
New Zealand shares fell, led lower by continued selling in A2 Milk Co and Comvita, while Ryman Healthcare and Heartland Bank gained.

 
Honey products exporter Comvita leads sharemarket down

2018-05-21 nzherald.co.nz
New Zealand shares dropped, led lower by Comvita as its possible takeover failed, with A2 Milk continuing last week's losses and Kiwi Property Group dropping on its earnings.

 
Weekly Commentary: Crisis Watch

2018-05-19 seekingalpha
Where to begin? Contagion… The Argentine peso dropped another 5.0% this week, bringing y-t-d losses to 23.7%. The Turkish lira fell 3.9%, boosting 2018 losses to 15.4%. As notable, the Brazilian real dropped 3.7% (down 11.5% y-t-d), and the South African rand sank 4.0% (down 3.0% y-t-d). The Colombian peso fell 3.0%, the Chilean peso 2.7%, the Mexican peso 2.7%, the Hungarian forint 2.3%, the Polish zloty 2.

 
Investors’ pessimism poses a risk to the economy, analysts say

2018-05-18 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com

 
Analysts say investors’ pessimism poses a risk to the economy

2018-05-17 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com

 
Indonesia Pledges ‘Stronger Measures’ as It Raises Key Rate - Bloomberg

2018-05-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Bargain-hunting Chinese make Japanese retail king Bic Camera a billionaire

2018-05-17 japantimes.co.jp
Japanese retail tycoon Ryuji Arai can thank a growing flock of Chinese spenders for his swelling fortune.

 
When Market Pessimism Becomes a Self-Fulfilling Prophecy - Bloomberg

2018-05-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
The Top Growth Risks Clouding Malaysia’s Outlook With Policy in Flux - Bloomberg

2018-05-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Japan Retail King a Billionaire Thanks to Bargain-Hunting Chinese - Bloomberg

2018-05-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Line, Marui and KDDI look for slice of the securities industry

2018-05-16 japantimes.co.jp
Companies in telecommunications, retail and other sectors are entering the securities industry in Japan, aiming to provide young people with financial services that can be conveniently used with credit cards or smartphones.

 
Nomura Holdings (NMR): Moving Average Crossover Alert

2018-05-15 zacks
Nomura Holdings, Inc. (NMR - Free Report) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front. Recently, the 50 Day Moving Average for NMR broke out below the 200 Day Simple Moving Average, suggesting short-term bearishness.

 
Asia to come out on top as emerging marts are shaken

2018-05-14 bworldonline
THE TURBULENCE seen across emerging markets is following a similar pattern to a crisis that rocked global trading more than two decades ago — it involved tequila.

2
NMR / Nomura Holdings, Inc. FORM 6-K (Current Report of Foreign Issuer)

2018-05-14 sec.gov
FORM 6-K FORM 6-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

 
JPMorgan applies to set up majority-owned securities business in China

2018-05-14 reuters
HONG KONG (Reuters) - JPMorgan Chase & Co (JPM.N) said on Monday it has applied to China’s securities regulator to set up a securities business in which the U.S. bank would own a majority stake under recently relaxed ownership rules.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 65535H208